SO
IPXL

STRS Ohio’s Impax Laboratories, Inc. IPXL Stock Holding History

STRS Ohio’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-64,800
Closed -$819K – 2073
2017
Q1 		$819K Sell
64,800
-1,400
-2% -$16.9K ﹤0.01% 945
2016
Q4 		$877K Buy
66,200
+44,800
+209% +$766K ﹤0.01% 919
2016
Q3 		$507K Sell
21,400
-800
-4% -$21.5K ﹤0.01% 1304
2016
Q2 		$639K Buy
22,200
+15,000
+208% +$489K ﹤0.01% 1134
2016
Q1 		$230K Sell
7,200
-3,200
-31% -$112K ﹤0.01% 1481
2015
Q4 		$444K Buy
10,400
+700
+7% +$28K ﹤0.01% 1325
2015
Q3 		$341K Sell
9,700
-300
-3% -$13.5K ﹤0.01% 1402
2015
Q2 		$459K Sell
10,000
-500
-5% -$23.7K ﹤0.01% 1356
2015
Q1 		$492K Buy
10,500
+6,100
+139% +$243K ﹤0.01% 1212
2014
Q4 		$139K Buy
4,400
+3,500
+389% +$102K ﹤0.01% 1507
2014
Q3 		$21K Sell
900
-42,700
-98% -$1.09M ﹤0.01% 1734
2014
Q2 		$1.31M Buy
43,600
+42,700
+4,744% +$1.15M 0.01% 668
2014
Q1 		$24K Buy
+900
New +$22.5K ﹤0.01% 1666

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

STRS Ohio's IPXL Position: Q2 2017 in Review

STRS Ohio sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 64,800 shares — an estimated $819K sold.

STRS Ohio first reported a position in IPXL in Q1 2014 and held it in 13 quarters. The position peaked at $1.31M in Q2 2014. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • STRS Ohio reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • STRS Ohio sold 64,800 Impax Laboratories, Inc. shares in Q2 2017, an estimated $819K.
  • STRS Ohio first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 13 quarters.
  • STRS Ohio's Impax Laboratories, Inc. position peaked at $1.31M in Q2 2014.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on STRS Ohio's 13F filing for Q2 2017, filed 26 Jul 2017.